ALFA FinderBSE filing, NSE: GICRE. Summary written from the filing by ALFA Finder's alert engine.
General Insurance Corporation of India: key numbers
- Share price
- ₹342.30
- Market cap
- ₹60,053 Cr
- Revenue (annual)
- ₹52,986 Cr
- Net profit (annual)
- ₹9,662 Cr
- P/E (TTM)
- 6.7×Sector 20.6×
- Promoter holding
- 77.40%+0.00% QoQ
- FII holding
- 2.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from General Insurance Corporation of India
All →General Insurance Corporation of India Earnings Call Transcript: Key Takeaways
Premium growth is strong, but Q2 profit fell year on year to ₹2,455.62 Cr as the claims ratio rose to 87.39%. Management deflected on catastrophe losses, combined-ratio targets and Ind AS impact.
General Insurance Corporation of India Investor Presentation: Key Takeaways
H1 FY27 GWP Rs 24,704 Cr, NWP Rs 23,226 Cr, PAT Rs 4,378 Cr, combined ratio 107.4%, ROE 16.4%, solvency 418%. Strategy: international expansion, cat reserves, digitisation.
General Insurance Corporation of India Results Update
GIC Re reported half-year ended 30 September 2026 gross premium of Rs.24,703.57 crore and profit after tax of Rs.4,377.66 crore. PAT fell 5.23% year on year.
General Insurance Corporation of India Q2 FY27 Results: Net Profit ₹2,966 Cr, Up 3.2% YoY
General Insurance Corporation of India reported revenue from operations of ₹13,540 Cr (+17.8% YoY) and net profit of ₹2,966 Cr (+3.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹2,966 Cr · +3.2% YoY
General Insurance Corporation of India Board Meeting Date
General Insurance Corporation of India gave prior notice that its board meets on 30 October 2026 to consider unaudited Q2 standalone and consolidated results. The trading window stays closed until 48 hours after results.
General Insurance Corporation of India Annual General Meeting
General Insurance Corporation of India issued a Postal Ballot notice to shareholders. The agenda includes the appointment of Shri Divesh Sehara as Government Nominee Director.
Other business update announcements
All →Cohance Lifesciences Business Update
Cohance Lifesciences disclosed that USFDA issued the Establishment Inspection Report for its Pashamylaram facility, classifying the inspection as Voluntary Action Indicated. The inspection is now concluded.
Religare Enterprises Business Update
Religare Finvest, a material subsidiary, resumed lending after RBI lifted its Corrective Action Plan. It disbursed its first Loan Against Property on 6 November 2026.
Purple Wave Infocom Business Update
Purple Wave signed a 5-year data integration agreement with BPCL for its Hygiair devices. The Rs 10 crore figure is indicative, not firm order value.
- Execution
- 5 years
Msafe Equipments Business Update
MSAFE Equipments announced a Dhanteras puja at its upcoming Mathura integrated manufacturing facility, expected to commence operations by May 2027. The release describes planned capacity expansion but reports no contract, order, or financial value.
Skyways Air Services Business Update
Skyways Air Services renewed its Global Annual Agreement with Qatar Airways for one year. The agreement's size is not quantifiable, so no value is assigned.
- From
- Qatar Airways Group Q.C.S.C.
- Execution
- 1 year from effective date 1 January 2026
Zydus Lifesciences Business Update
Zydus Lifesciences' subsidiary presented Phase 2b trial data for investigational saroglitazar in MASH at AASLD 2026. The drug showed higher steatohepatitis resolution than placebo, but its safety and effectiveness for this use are not yet established.